Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Development of of A Novel Therapeutic to Aid Tobacco Smoking Cessation in Persons With Schizophrenia or Schizoaffective Disorder

NCT02230384 is registered in ClinicalTrials.gov with K.N. Roy Chengappa as lead sponsor.

NCT NCT02230384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02230384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Development of of A Novel Therapeutic to Aid Tobacco Smoking Cessation in Persons With Schizophrenia or Schizoaffective Disorder
Lead sponsor
K.N. Roy Chengappa
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
March 9, 2017
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation